← Back to Clinical Trials
Recruiting NCT06734000

NCT06734000 Cohorte COSCINUS - Biocollection

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06734000
Status Recruiting
Phase
Sponsor Nantes University Hospital
Condition Spinal Cord Injury
Study Type OBSERVATIONAL
Enrollment 105 participants
Start Date 2024-12-13
Primary Completion 2032-10-10

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 105 participants in total. It began in 2024-12-13 with a primary completion date of 2032-10-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

COSCINUS is a standardized framework for evaluating temporal trends in SCI causes, SCI characteristics, and demographic patterns. It allows a precise estimation of medical complications' incidence, their evolution over time, as well risk factors influencing these complications, including management modalities. Moreover, COSCINUS provides a high-quality research platform, including clinical, epidemiological, biostatistical, and IT expertise, thereby promoting fundamental research in spinal cord injury and related autonomic dysfunctions. As a national epidemiological tool, COSCINUS offers unique analytical perspectives, promising significant contributions to the understanding and management of spinal cord injuries.

Eligibility Criteria

Inclusion Criteria: * All individuals with spinal cord injury admitted to the neurological PRM department of the Nantes University Hospital at the initial phase of development of the paraplegia or tetraplegia could participate, regardless the clinical neurological status. Exclusion Criteria: * Patients not covered by social security.

Contact & Investigator

Central Contact

Brigitte Perrouin Verbe

✉ bp-prom-regl@chu-nantes.fr

📞 +33 2 53 48 28 35

Frequently Asked Questions

Who can join the NCT06734000 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, studying Spinal Cord Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06734000 currently recruiting?

Yes, NCT06734000 is actively recruiting participants. Contact the research team at bp-prom-regl@chu-nantes.fr for enrollment information.

Where is the NCT06734000 trial being conducted?

This trial is being conducted at Nantes, France.

Who is sponsoring the NCT06734000 clinical trial?

NCT06734000 is sponsored by Nantes University Hospital. The trial plans to enroll 105 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology